about to breakout - get on board now, page-103

sirtex breakout to 3.80 near The next wave is to $ 3.50-3.90 which is a $ 60-70 % short term up move. The share has topped the 10,20,50,100, and 200 day moving averages with a very firmly positive MACD for the first time in over 10 mos. The technicals and fundamentals are vastly improving from the time when Cephalon Australia bid $ 4.85 a share which was rejected 2 years ago. The co is in over 130 centers worldwide and the Sir Spheres are more valuable than 2 years ago as they have been found to work with different comnpanies's chemotheraoeutics and in different indications of metastatic disease to the liver. There will be a premium on the share as multiple cos can use the Sir Spheres to work synergistically with their own product and arguably it is worth significantly more than the old offer. Mayne has already stated in shedding their unprofitable hospital divisions that they are on the prowl for higher margined oncology companies and Sirtex could fit the bill as this would preferably keep the FDa approved co in Australia as trheir own success in biotech. A US based co could snap it up also to create a bidding up. However now HH, Dr Gray and big institutions control 80 % of the share and they could control the bid much more easily than 2 years ago when it was rejected by enough shareholders since only less than about 50 % was closely held then. The move up now could be more dramatic as analysts pile on after realizing the positive developments .